Issue |
Section |
Title |
File |
Vol 17, No 2 (2018) |
ORIGINAL ARTICLES |
Donor-related factors affecting the outcome of hematopoietic stem cell transplantations in children |
 (Rus)
|
Vol 17, No 4 (2018) |
ORIGINAL ARTICLES |
Mucopolysaccharidosis I type: new management |
 (Rus)
|
Vol 18, No 2 (2019) |
ORIGINAL ARTICLES |
The experience of hematopoietic stem cell transplantation in primary immunodeficiencies in the Russian Children's Clinical Hospital |
 (Rus)
|
Vol 18, No 2 (2019) |
ORIGINAL ARTICLES |
Practice of allogeneic hematopoietic stem cell transplantation for infantile autosomal recessive osteopetrosis |
 (Rus)
|
Vol 19, No 2 (2020) |
ORIGINAL ARTICLES |
The efficacy of the regimens of “graft versus host” disease prophylaxis after hematopoietic stem cell transplantation from unrelated donors in children: single center experience |
 (Rus)
|
Vol 19, No 4 (2020): supplement |
MATERIALS OF THE 3rd WORKING MEETING OF ALLERGISTS-IMMUNOLOGISTS |
The use of post-transplant cyclophosphamide in haploidentical hematopoietic stem cell transplantation in patients with severe combined immunodeficiency. The experience of the Russian Children’s Clinical Hospital |
 (Rus)
|
Vol 20, No 2 (2021) |
ORIGINAL ARTICLES |
BCG vaccine–related complications in patients with primary immunodeficiencies after allogeneic hematopoietic stem cell transplantation |
 (Rus)
|
Vol 21, No 2 (2022) |
ORIGINAL ARTICLES |
The results of ten years’ experience in allogeneic hematopoietic stem cell transplantation at the Russian Children’s Clinical Hospital |
 (Rus)
|
Vol 21, No 3 (2022) |
CLINICAL OBSERVATIONS |
MECOM-associated syndrome: a literature review and case reports |
 (Rus)
|
Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
The results of a study on the effectiveness 37 and safety of treatment with vemurafenib and cytarabine/2-chloro-2′-deoxyadenosine combination in patients with Langerhans cell histiocytosis with BRAFV600E mutation |
 (Rus)
|